Understanding the Late Stage Chronic Kidney Disease Drugs Market’s Growth Prospects from 2024 to 2033
Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!
2024-2033 Forecast: What is the Projected Growth Rate for the Late Stage Chronic Kidney Disease Drugs Market?
The market size of drugs for late-stage chronic kidney disease has seen significant expansion in previous years. It is anticipated to increase from $6.38 billion in 2023 to $7.16 billion in 2024, demonstrating a compound annual growth rate (CAGR) of 12.2%. The historic development was fueled by advancements in diagnostic methods, an ageing populace, a rise in diabetes and hypertension cases, heightened knowledge of kidney diseases, and the growth of pharmaceutical research and development.
Anticipations point towards a swift expansion in the market size of drugs for late-stage chronic kidney disease in the ensuing years. The market is predicted to escalate to $10.94 billion by 2028, advancing at a compound annual growth rate (CAGR) of 11.2%. This anticipated growth within the specified period may be credited to factors such as increased spending on healthcare, the adoption of precision medicine methodology, a rising focus on regenerative medicine, an intensified emphasis on patient-oriented care, and worldwide initiatives to raise awareness about kidney diseases. The forecast period is set to witness certain trend changes including the expansion of regenerative medicine therapies, the ascent in telemedicine services for handling chronic kidney disease, the evolution of combination therapies, focus on strategies for early intervention, and the growing attraction towards diagnostics based on biomarkers.
Claim Your Free Sample of the Global Late Stage Chronic Kidney Disease Drugs Market Report Today!
https://www.thebusinessresearchcompany.com/sample.aspx?id=12196&type=smp
What Are the Main Drivers Behind the Growth of the late stage chronic kidney disease drugs Market?
The increasing incidence of long-term kidney diseases is predicted to stimulate the expansion of the late-stage chronic kidney disease drug market. These diseases encompass a variety of conditions that impact the kidneys’ structure and function. Drugs for late-stage chronic kidney disease aim to regulate blood pressure in patients, reduce protein loss to prevent further kidney degradation, handle symptoms, and sidestep complications. For instance, the Centers for Disease Control and Prevention, a Department of Health and Human Services in the US, reported in July 2022 that approximately 15%, or 37 million people in the US, were suffering from kidney ailments. The occurrence rate is 12% among people aged 45-64, while those aged 18 to 44 show the lowest prevalence at 6% in 2021. As such, the high frequency of chronic kidney disease is propelling the growth of the late-stage chronic kidney disease drug market.
What Are the Primary Segments of the Late Stage Chronic Kidney Disease Drugs Market?
1) By Product Type: Calcimimetics, Vitamin D, Sterols, Potassium Binders, Calcium-Based Phosphate Binders
2) By Indication Type: Late Stage Chronic Kidney Disease Induced Hyperparathyroidism, Late Stage Chronic Kidney Disease Induced Hyperphosphatemia, Late Stage Chronic Kidney Disease Induced Hyperkalemia
3) By Distribution Channel: Hospital Pharmacies, Online Pharmacies, Retail Pharmacies
Which Trends Are Revolutionizing the Late Stage Chronic Kidney Disease Drugs Market?
The trend of product innovation is picking up steam in the late-stage chronic kidney disease drug market. Major market players are creating new drug products to maintain their dominance. For example, in February 2022, Bayer, a pharmaceutical and biotechnology firm from Germany, introduced Kerendia (finerenone) in India. This first-in-class non-steroidal, selective mineralocorticoid receptor antagonist should be used by patients suffering from type two diabetes and chronic renal disease. It operates by inhibiting the over-stimulation of the mineralocorticoid receptor (MR), which is believed to contribute to the onset of chronic kidney disease (CKD) and cardiovascular damage.
Order Now for Fast Delivery of Your Late Stage Chronic Kidney Disease Drugs Market Report!
Which Geographical Regions Are Pioneering Growth in the Late Stage Chronic Kidney Disease Drugs Market?
North America was the largest region in the late stage chronic kidney disease drugs market in 2023. The regions covered in the late stage chronic kidney disease drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The Late Stage Chronic Kidney Disease Drugs Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the late stage chronic kidney disease drugs market, its market share, and analyzes key competitors along with their market positions.
The Table Of Content For The Late Stage Chronic Kidney Disease Drugs Market Include
1. Late Stage Chronic Kidney Disease Drugs Market Executive Summary
2. Late Stage Chronic Kidney Disease Drugs Market Segments
3. Late Stage Chronic Kidney Disease Drugs Market Size And Template Market Growth Rate
4. Key Late Stage Chronic Kidney Disease Drugs Market Trends
5. Major Late Stage Chronic Kidney Disease Drugs Market Drivers
……
25. Key Mergers And Acquisitions In The Late Stage Chronic Kidney Disease Drugs Market
26. Top Late Stage Chronic Kidney Disease Drugs Companies
27. Late Stage Chronic Kidney Disease Drugs Market Opportunities And Strategies
28. Late Stage Chronic Kidney Disease Drugs Market, Conclusions And Recommendations
29. Appendix
Learn More About The Business Research Company
The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
